Healthcare provider profile · identity verified

Daniel J Fitzpatrick, D.O.

Family Practice · VIENNA, OH · NPI 1952357758

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	439	178
Lisinopril	Lisinopril	327	126
Levothyroxine Sodium	Levothyroxine Sodium	297	110
Metoprolol Succinate	Metoprolol Succinate	203	72
Omeprazole	Omeprazole	195	78
Losartan Potassium	Losartan Potassium	194	79
Amlodipine Besylate	Amlodipine Besylate	153	62
Pantoprazole Sodium	Pantoprazole Sodium	149	64
Metformin Hcl	Metformin Hcl	148	55
Simvastatin	Simvastatin	136	47
Tamsulosin Hcl	Tamsulosin Hcl	134	50
Gabapentin	Gabapentin	131	44
Furosemide	Furosemide	128	50
Potassium Chloride	Potassium Chloride	119	36
Clopidogrel	Clopidogrel Bisulfate	117	37
Albuterol Sulfate Hfa	Albuterol Sulfate	114	48
Meloxicam	Meloxicam	90	31
Eliquis	Apixaban	87	26
Rosuvastatin Calcium	Rosuvastatin Calcium	83	39
Fluticasone Propionate	Fluticasone Propionate	79	30
Sertraline Hcl	Sertraline Hcl	79	28
Metoprolol Tartrate	Metoprolol Tartrate	78	31
Metformin Hcl Er	Metformin Hcl	70	31
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	70	11
Carvedilol	Carvedilol	68	24
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	62	24
Alprazolam	Alprazolam	60	11
Duloxetine Hcl	Duloxetine Hcl	60	16
Prednisone	Prednisone	58	45
Allopurinol	Allopurinol	57	23
Hydrochlorothiazide	Hydrochlorothiazide	56	24
Hydralazine Hcl	Hydralazine Hcl	55	20
Meclizine Hcl	Meclizine Hcl	55	23
Azithromycin	Azithromycin	52	48
Celecoxib	Celecoxib	52	17
Ibuprofen	Ibuprofen	52	28
Jardiance	Empagliflozin	51	19
Atenolol	Atenolol	50	19
Lorazepam	Lorazepam	50	14
Famotidine	Famotidine	48	14
Ropinirole Hcl	Ropinirole Hcl	47	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	16
Synthroid	Levothyroxine Sodium	46	19
Fluoxetine Hcl	Fluoxetine Hcl	45	13
Montelukast Sodium	Montelukast Sodium	45	16
Pregabalin	Pregabalin	45	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	18
Zolpidem Tartrate	Zolpidem Tartrate	44	11
Trazodone Hcl	Trazodone Hcl	42	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	40	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	16
Pravastatin Sodium	Pravastatin Sodium	40	18
Spironolactone	Spironolactone	39	15
Tizanidine Hcl	Tizanidine Hcl	38	14
Escitalopram Oxalate	Escitalopram Oxalate	36	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	11
Finasteride	Finasteride	34	14
Pioglitazone Hcl	Pioglitazone Hcl	33	17
Bumetanide	Bumetanide	32	12
Doxycycline Hyclate	Doxycycline Hyclate	32	29
Glimepiride	Glimepiride	32	14
Xarelto	Rivaroxaban	32	12
Fenofibrate	Fenofibrate Nanocrystallized	31	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	15
Clonidine Hcl	Clonidine Hcl	29	13
Diclofenac Sodium	Diclofenac Sodium	29	18
Entresto	Sacubitril/Valsartan	29	suppressed
Farxiga	Dapagliflozin Propanediol	29	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	12
Ketoconazole	Ketoconazole	28	15
Levetiracetam	Levetiracetam	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Vascepa	Icosapent Ethyl	26	suppressed
Tramadol Hcl	Tramadol Hcl	25	suppressed
Baclofen	Baclofen	24	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Mupirocin	Mupirocin	24	17
Donepezil Hcl	Donepezil Hcl	23	suppressed
Ozempic	Semaglutide	20	suppressed
Cartia Xt	Diltiazem Hcl	19	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Fenofibrate	Fenofibrate,micronized	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Dexamethasone	Dexamethasone	15	13
Dutasteride	Dutasteride	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	11
Clonazepam	Clonazepam	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Linzess	Linaclotide	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Movantik	Naloxegol Oxalate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error